Alterity Therapeutics (ATHE) Current Leases (2020 - 2025)

Alterity Therapeutics' Current Leases history runs 6 years deep, the most recent figure standing at $42980.1 for Q4 2025.

• In Q4 2025, Current Leases rose 4.8% year-over-year to $42980.1; the TTM figure through Dec 2025 stood at $42980.1 (up 4.8% YoY), while the FY2025 annual figure was $56707.2, up 5193.25% from the prior year.
• Current Leases was $42980.1 for Q4 2025 at Alterity Therapeutics, down from $56707.2 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $71632.9 in Q2 2023 to a low of $21365.9 in Q2 2021.
• Historically, Current Leases has averaged $49368.5 across 5 years, with a median of $42980.1 in 2025.
• The sharpest annual moves came in 2022 and 2025: Current Leases jumped 93.2% in 2022, then fell 19.68% in 2025.
• A 5-year view of Current Leases shows it stood at $21365.9 in 2021, then surged by 93.2% to $41280.0 in 2022, then soared by 73.53% to $71632.9 in 2023, then slumped by 42.75% to $41011.6 in 2024, then advanced by 4.8% to $42980.1 in 2025.
• The last three Current Leases figures came in at $42980.1 (Q4 2025), $56707.2 (Q2 2025), and $41011.6 (Q4 2024), per Business Quant data.